Home » Venture Capital » All Companies

All Companies

Company Descriptionsort icon Status Initial Date
<a href="/venture-capital/all-companies/bizo">Bizo</a> Private 2008 View Profile
<a href="/venture-capital/all-companies/zoom-info">Zoom Info</a> Private 2000 View Profile
<a href="/venture-capital/all-companies/datacore">DataCore</a> Private 1998 View Profile
<a href="/venture-capital/all-companies/avedro-inc">Avedro, Inc.</a> Advancing the science and technology of corneal crosslinking. Private 2009 View Profile
<a href="/venture-capital/all-companies/concert-pharmaceuticals-inc">Concert Pharmaceuticals, Inc.</a> Applying the company’s DCE Platform® (deuterated chemical entity platform) to create novel and differentiated small molecule drugs. Private 2006 View Profile
<a href="/venture-capital/all-companies/joule-unlimited-inc">Joule Unlimited, Inc.</a> Capitalizing on the global abundance of waste CO2 to economically produce renewable fuels and chemicals. Private 2007 View Profile
<a href="/venture-capital/all-companies/novomer-inc">Novomer, Inc.</a> Commercializing a family of low-cost, high-performance, sustainable polymers and other chemicals. Private 2007 View Profile
<a href="/venture-capital/all-companies/midori-renewables-inc">Midori Renewables Inc.</a> Commercializing chemical catalysts for upgrading waste biomass to fuels, chemicals, and materials. Private 2010 View Profile
<a href="/venture-capital/all-companies/eleven-biotherapeutics-inc">Eleven Biotherapeutics, Inc.</a> Creating novel and differentiated biotherapeutics: first-of-a-kind protein-based drugs. Private 2008 View Profile
<a href="/venture-capital/all-companies/tetraphase-pharmaceuticals-inc">Tetraphase Pharmaceuticals, Inc.</a> Creating novel antibiotics for serious and life-threatening multi-drug resistant infections. Public 2006 View Profile
<a href="/venture-capital/all-companies/brainshark-inc">Brainshark, Inc.</a> Delivers solutions for rich-media communication. Private 1999 View Profile
<a href="/venture-capital/all-companies/ensemble-therapeutics-corporation">Ensemble Therapeutics Corporation</a> Deploying its proprietary chemistry platforms to develop a novel class of therapeutics known as “Ensemblins”. Private 2004 View Profile
<a href="/venture-capital/all-companies/cytyc">CYTYC</a> Design, development, manufacturing, and marketing of medical devices focused on women's health Public 1989 View Profile
<a href="/venture-capital/all-companies/perseptive-biosystems">PerSeptive BioSystems</a> Developer of high-technology purification, analysis and synthesis products Acquired 1991 View Profile
<a href="/venture-capital/all-companies/cgi-pharmaceuticals-inc">CGI Pharmaceuticals, Inc.</a> Developing small molecule therapeutics for multiple oncology and immunology-based indications Acquired 2001 View Profile
<a href="/venture-capital/all-companies/bind-therapeutics-inc">BIND Therapeutics, Inc.</a> Developing a new class of highly selective targeted and programmable therapeutics called Accurins™. Private 2007 View Profile
<a href="/venture-capital/all-companies/taris-biomedical-inc">TARIS Biomedical, Inc.</a> Developing a pipeline of innovative treatments for bladder diseases. Private 2008 View Profile
<a href="/venture-capital/all-companies/intio">INTIO</a> Developing a software platform to support the emerging interventional oncology market. Private 2005 View Profile
<a href="/venture-capital/all-companies/medidametrics-inc">MedidaMETRICS, Inc.</a> Developing activity-based costing systems for healthcare providers. Private 2010 View Profile
<a href="/venture-capital/all-companies/seventh-sense-biosystems-inc">Seventh Sense Biosystems, Inc.</a> Developing an array of products based on the company's proprietary TAP™ (Touch Activated Phlebotomy) painless blood collection platform. Private 2007 View Profile